Palisade Bio, Inc. (PALI)
USD 1.75
(-7.89%)
USD 1.75
(-7.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 250 Thousand | - | - | 13.52 Thousand | 15.39 Thousand | 260 Thousand |
| Cost of Revenue | 4000.00 | 167 Thousand | 168 Thousand | 146 Thousand | - | -990 Thousand |
| Gross Profit | 246 Thousand | -167 Thousand | -168 Thousand | -132.48 Thousand | 15.39 Thousand | 1.25 Million |
| Operating Expenses | 13.32 Million | 15.31 Million | 41.85 Million | 9.29 Million | 8.5 Million | 8.33 Million |
| Selling, General and Administrative Expenses | 6.2 Million | 8.76 Million | 9.3 Million | 6.19 Million | 4.44 Million | 4.37 Million |
| Research and Development Expenses | 6.89 Million | 6.54 Million | 32.54 Million | 3.09 Million | 4.06 Million | 3.96 Million |
| Other Expenses | 225 Thousand | 158 Thousand | -1.74 Million | 13 Thousand | - | - |
| Cost and Expenses | 13.32 Million | 15.31 Million | 41.85 Million | 9.29 Million | 8.64 Million | 8.51 Million |
| Operating Income | -13.07 Million | -15.72 Million | -41.85 Million | -9.29 Million | -8.63 Million | -8.25 Million |
| Interest Expense | 15 Thousand | 13 Thousand | 2.39 Million | 235 Thousand | 8920.00 | 7698.00 |
| Income Tax Expense | - | -1.46 Million | 655 Thousand | 248 Thousand | 288.96 Thousand | 3.34 Million |
| Earnings before Tax | -12.3 Million | -14.26 Million | -26.61 Million | -10.32 Million | -8.35 Million | -4.92 Million |
| Net Income | -12.3 Million | -12.79 Million | -27.27 Million | -10.57 Million | -8.35 Million | -4.92 Million |
| Earnings Per Share Basic | -27.01 | -218.14 | -2608.92 | -190.50 | -221.64 | -270.35 |
| Earnings Per Share Diluted | -27.01 | -218.09 | -2187.98 | -190.50 | -221.64 | -270.35 |
| Weighted Average Shares Outstanding | 456.01 Thousand | 58.67 Thousand | 10.45 Thousand | 55.48 Thousand | 37.68 Thousand | 18.21 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 456.01 Thousand | 58.68 Thousand | 12.46 Thousand | 55.48 Thousand | 37.68 Thousand | 18.21 Thousand |
| Gross Margin | 0.98 | - | - | -9.80 | 1.00 | 4.81 |
| EBIT Margin | -49.12 | - | - | -748.67 | -551.37 | -31.05 |
| Profit Margin | -49.20 | - | - | -781.80 | -542.53 | -18.94 |
| EBITDA | -12.28 Million | -15.3 Million | -24.05 Million | -9.94 Million | -8.19 Million | -4.73 Million |
| Earnings Before Tax Margin | -52.28 | - | - | -687.65 | -560.72 | -31.77 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 250 Thousand | -250 Thousand | - | - |
| Cost of Revenue | 1000.00 | 1000.00 | 4000.00 | 54 Thousand | 1000.00 | 27 Thousand |
| Gross Profit | -1000.00 | -1000.00 | 246 Thousand | -304 Thousand | -1000.00 | -27 Thousand |
| Operating Expenses | 4.21 Million | 3.67 Million | 13.09 Million | 3.29 Million | 3.77 Million | 3.6 Million |
| Selling, General and Administrative Expenses | 1.58 Million | 1.45 Million | - | 1.55 Million | 1.67 Million | 1.43 Million |
| Research and Development Expenses | 2.62 Million | 2.21 Million | - | 1.73 Million | 1.74 Million | 2.17 Million |
| Other Expenses | 133 Thousand | 147 Thousand | 785 Thousand | 187 Thousand | 362 Thousand | 219 Thousand |
| Cost and Expenses | 4.21 Million | 3.67 Million | 13.09 Million | 3.29 Million | 3.77 Million | 3.6 Million |
| Operating Income | -4.21 Million | -3.67 Million | -12.84 Million | -3.29 Million | -3.77 Million | -3.6 Million |
| Interest Expense | -2000.00 | 1000.00 | 15 Thousand | 4000.00 | -8000.00 | 3000.00 |
| Income Tax Expense | -1000.00 | -42.27 Thousand | 16 Thousand | -32 Thousand | -1000.00 | 222 Thousand |
| Earnings before Tax | -4.08 Million | -3.52 Million | -12.3 Million | -2.97 Million | -3.59 Million | -3.39 Million |
| Net Income | -4.08 Million | -3.52 Million | -12.31 Million | -2.97 Million | -3.59 Million | -3.39 Million |
| Earnings Per Share Basic | -3.32 | -4.19 | - | -4.81 | -7.35 | -7.95 |
| Earnings Per Share Diluted | -3.32 | -4.19 | - | -4.81 | -7.34 | -7.93 |
| Weighted Average Shares Outstanding | 1.22 Million | 842.2 Thousand | 456.01 Thousand | 617.83 Thousand | 489.25 Thousand | 426.79 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.22 Million | 842.2 Thousand | 456.01 Thousand | 617.83 Thousand | 489.62 Thousand | 427.86 Thousand |
| Gross Margin | - | - | 0.98 | 1.22 | - | - |
| EBIT Margin | - | - | - | 13.16 | - | - |
| Profit Margin | - | - | -49.26 | 11.88 | - | - |
| EBITDA | -4.21 Million | -3.67 Million | - | -3.29 Million | -3.77 Million | -3.38 Million |
| Earnings Before Tax Margin | - | - | -51.38 | 13.16 | - | - |
CACO
016610
BIOCON
QRON
601008
8273